SI1165528T1 - Novi derivati morfolina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo - Google Patents

Novi derivati morfolina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo

Info

Publication number
SI1165528T1
SI1165528T1 SI200030536T SI200030536T SI1165528T1 SI 1165528 T1 SI1165528 T1 SI 1165528T1 SI 200030536 T SI200030536 T SI 200030536T SI 200030536 T SI200030536 T SI 200030536T SI 1165528 T1 SI1165528 T1 SI 1165528T1
Authority
SI
Slovenia
Prior art keywords
derivatives
production
pharmaceutical preparations
preparations containing
novel morpholine
Prior art date
Application number
SI200030536T
Other languages
English (en)
Inventor
Jean Philippe Ducoux
Xavier Emonds-Alt
Patrick Gueule
Vincenzo Proietto
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of SI1165528T1 publication Critical patent/SI1165528T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/10Antiepileptics; Anticonvulsants for petit-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200030536T 1999-03-25 2000-03-21 Novi derivati morfolina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo SI1165528T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9903854A FR2791346B3 (fr) 1999-03-25 1999-03-25 Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
EP00911009A EP1165528B1 (fr) 1999-03-25 2000-03-21 Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR2000/000695 WO2000058292A1 (fr) 1999-03-25 2000-03-21 Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
SI1165528T1 true SI1165528T1 (sl) 2005-02-28

Family

ID=9543720

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030536T SI1165528T1 (sl) 1999-03-25 2000-03-21 Novi derivati morfolina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo

Country Status (41)

Country Link
US (1) US6506750B1 (sl)
EP (1) EP1165528B1 (sl)
JP (1) JP3853155B2 (sl)
KR (1) KR100696340B1 (sl)
CN (1) CN100422160C (sl)
AR (1) AR023139A1 (sl)
AT (1) ATE275136T1 (sl)
AU (1) AU756855B2 (sl)
BG (1) BG64623B1 (sl)
BR (1) BR0009281B1 (sl)
CA (1) CA2366829C (sl)
CO (1) CO5160340A1 (sl)
CZ (1) CZ300911B6 (sl)
DE (1) DE60013418T2 (sl)
DK (1) DK1165528T3 (sl)
EE (1) EE04525B1 (sl)
ES (1) ES2226794T3 (sl)
FR (1) FR2791346B3 (sl)
HK (1) HK1042092B (sl)
HR (1) HRP20010704B1 (sl)
HU (1) HUP0201863A3 (sl)
ID (1) ID29871A (sl)
IL (2) IL145041A0 (sl)
IS (1) IS2338B (sl)
ME (2) ME00057B (sl)
MX (1) MXPA01009643A (sl)
NO (1) NO321576B1 (sl)
NZ (1) NZ513674A (sl)
PE (1) PE20001596A1 (sl)
PL (1) PL205318B1 (sl)
PT (1) PT1165528E (sl)
RS (1) RS50085B (sl)
RU (1) RU2222537C2 (sl)
SI (1) SI1165528T1 (sl)
SK (1) SK286977B6 (sl)
TR (1) TR200102639T2 (sl)
TW (1) TW534906B (sl)
UA (1) UA73931C2 (sl)
UY (1) UY26079A1 (sl)
WO (1) WO2000058292A1 (sl)
ZA (1) ZA200106981B (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044172A1 (en) * 2000-11-28 2002-06-06 Smithkline Beecham P.L.C. Morpholine derivatives as antagonists of orexin receptors
FR2824828B1 (fr) * 2001-05-21 2005-05-20 Sanofi Synthelabo Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant
GB0228787D0 (en) * 2002-12-10 2003-01-15 Pfizer Ltd Morpholine dopamine agonists
US7452992B2 (en) 2002-12-13 2008-11-18 Smithkline Beecham Corporation Heterocyclic compounds as CCR5 antagonists
JO2485B1 (en) * 2002-12-23 2009-01-20 شركة جانسين فارماسوتيكا ان. في 1-Piperidine-3-Yl-4-Piperidine-4-Yl-Piperazine derivatives substituted and used as quinine antagonists
AU2004308935A1 (en) * 2003-12-22 2005-07-14 Schering Corporation Pharmaceutical compositions
FR2873373B1 (fr) * 2004-07-23 2006-09-08 Sanofi Synthelabo Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
CN103142569B (zh) * 2013-02-27 2016-01-20 南京医科大学 2,6-二异丙基苯甲酸及其衍生物作为神经保护剂的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ3134U1 (cs) * 1995-01-10 1995-03-17 Pavel Ing. Janda Rotor universálního radiálního ventilátoru
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
US5780466A (en) * 1995-01-30 1998-07-14 Sanofi Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
RU2135494C1 (ru) * 1995-12-01 1999-08-27 Санкио Компани Лимитед Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
JP3192631B2 (ja) * 1997-05-28 2001-07-30 三共株式会社 飽和複素環化合物からなる医薬
HUP0004321A3 (en) * 1997-12-04 2002-04-29 Sankyo Co Alicyclic acylated heterocyclic derivatives and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
BR0009281A (pt) 2002-01-22
EP1165528A1 (fr) 2002-01-02
HUP0201863A2 (hu) 2002-12-28
PT1165528E (pt) 2005-01-31
YU68201A (sh) 2004-03-12
PL351317A1 (en) 2003-04-07
NO20014632D0 (no) 2001-09-24
KR100696340B1 (ko) 2007-03-20
AU756855B2 (en) 2003-01-23
ES2226794T3 (es) 2005-04-01
DK1165528T3 (da) 2005-01-10
IL145041A (en) 2010-11-30
JP3853155B2 (ja) 2006-12-06
BR0009281B1 (pt) 2011-05-17
HK1042092B (zh) 2005-04-22
ATE275136T1 (de) 2004-09-15
BG64623B1 (bg) 2005-09-30
EE04525B1 (et) 2005-08-15
NZ513674A (en) 2003-05-30
US6506750B1 (en) 2003-01-14
AR023139A1 (es) 2002-09-04
MEP12008A (en) 2010-06-10
ID29871A (id) 2001-10-18
WO2000058292A1 (fr) 2000-10-05
RS50085B (sr) 2009-01-22
BG105923A (en) 2002-05-31
DE60013418T2 (de) 2005-09-22
HRP20010704A2 (en) 2002-08-31
CA2366829C (fr) 2007-05-15
CZ20013365A3 (cs) 2002-01-16
NO321576B1 (no) 2006-06-06
CO5160340A1 (es) 2002-05-30
NO20014632L (no) 2001-11-26
IS6063A (is) 2001-08-24
DE60013418D1 (de) 2004-10-07
SK286977B6 (sk) 2009-08-06
EE200100499A (et) 2002-12-16
ME00057B (me) 2010-10-10
EP1165528B1 (fr) 2004-09-01
SK13462001A3 (sk) 2002-05-09
UY26079A1 (es) 2000-10-31
CN1353698A (zh) 2002-06-12
CN100422160C (zh) 2008-10-01
ZA200106981B (en) 2002-10-24
HK1042092A1 (en) 2002-08-02
FR2791346B3 (fr) 2001-04-27
PL205318B1 (pl) 2010-04-30
CZ300911B6 (cs) 2009-09-09
RU2222537C2 (ru) 2004-01-27
AU3301600A (en) 2000-10-16
IL145041A0 (en) 2002-06-30
TW534906B (en) 2003-06-01
MXPA01009643A (es) 2002-05-14
JP2002540195A (ja) 2002-11-26
HUP0201863A3 (en) 2003-03-28
FR2791346A1 (fr) 2000-09-29
KR20010108381A (ko) 2001-12-07
TR200102639T2 (tr) 2002-02-21
PE20001596A1 (es) 2001-04-01
IS2338B (is) 2008-02-15
CA2366829A1 (fr) 2000-10-05
HRP20010704B1 (en) 2005-04-30
UA73931C2 (en) 2005-10-17

Similar Documents

Publication Publication Date Title
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
ZA200109859B (en) 6-Alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations.
HUP0000748A2 (en) 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0105478A3 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
HRP20010115B1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
HUP0105479A3 (en) Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
ZA988711B (en) New tetracycles, process for their production and pharmaceutical preparations containing these compounds.
HK1042092B (zh) 新的嗎啉衍生物,其製備方法和含有它們的藥物組合物
HUP0200928A3 (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
IL144363A0 (en) (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
HUP0201916A2 (en) Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
AU7517800A (en) 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments
AU2942100A (en) Vitamin d derivatives and process for the preparation thereof
AU2003204342A1 (en) Piperazine derivatives and process for the preparation thereof
SI1194415T1 (sl) Novi piperazinil-alkiltiopirimidinski derivati, farmacevtski sestavki, ki jih vsebujejo, in postopek za njihovo pripravo
SI1098874T1 (sl) Benzociklohepteni, postopek za njihovo pripravo, farmacevtski pripravki, ki jih vsebujejo, kot tudi njihova uporaba za pripravo zdravil
IL117302A (en) Cryptophycin derivatives, methods for the production thereof and pharmaceutical compositions containing the same